98 related articles for article (PubMed ID: 22917608)
1. Effects of valproic acid on the expression of trophic factors in human bone marrow mesenchymal stromal cells.
Cho GW; Kang BY; Kim KS; Kim SH
Neurosci Lett; 2012 Sep; 526(2):100-5. PubMed ID: 22917608
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells.
Jeong SG; Ohn T; Kim SH; Cho GW
Neurosci Lett; 2013 Oct; 554():22-7. PubMed ID: 24021810
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis reveals KRIT1 as a modulator for the antioxidant effects of valproic acid in human bone-marrow mesenchymal stromal cells.
Jung KH; Han DM; Jeong SG; Choi MR; Chai YG; Cho GW
Drug Chem Toxicol; 2015; 38(3):286-92. PubMed ID: 25203678
[TBL] [Abstract][Full Text] [Related]
4. The functional deficiency of bone marrow mesenchymal stromal cells in ALS patients is proportional to disease progression rate.
Koh SH; Baik W; Noh MY; Cho GW; Kim HY; Kim KS; Kim SH
Exp Neurol; 2012 Jan; 233(1):472-80. PubMed ID: 22119626
[TBL] [Abstract][Full Text] [Related]
5. Impact of lenalidomide on the functional properties of human mesenchymal stromal cells.
Wobus M; Benath G; Ferrer RA; Wehner R; Schmitz M; Hofbauer LC; Rauner M; Ehninger G; Bornhäuser M; Platzbecker U
Exp Hematol; 2012 Oct; 40(10):867-76. PubMed ID: 22705469
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of DNA methylation enhances HLA-G expression in human mesenchymal stem cells.
Teklemariam T; Purandare B; Zhao L; Hantash BM
Biochem Biophys Res Commun; 2014 Sep; 452(3):753-9. PubMed ID: 25204503
[TBL] [Abstract][Full Text] [Related]
7. Trophic effects of mesenchymal stem cells in chondrocyte co-cultures are independent of culture conditions and cell sources.
Wu L; Prins HJ; Helder MN; van Blitterswijk CA; Karperien M
Tissue Eng Part A; 2012 Aug; 18(15-16):1542-51. PubMed ID: 22429306
[TBL] [Abstract][Full Text] [Related]
8. HIV protease inhibitors induce senescence and alter osteoblastic potential of human bone marrow mesenchymal stem cells: beneficial effect of pravastatin.
Hernandez-Vallejo SJ; Beaupere C; Larghero J; Capeau J; Lagathu C
Aging Cell; 2013 Dec; 12(6):955-65. PubMed ID: 23795945
[TBL] [Abstract][Full Text] [Related]
9. Effect of bFGF on HLA-DR expression of human bone marrow-derived mesenchymal stem cells.
Dighe PA; Viswanathan P; Mruthunjaya AK; Seetharam RN
J Stem Cells; 2013; 8(1):43-57. PubMed ID: 24459812
[TBL] [Abstract][Full Text] [Related]
10. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities.
Ponte AL; Marais E; Gallay N; Langonné A; Delorme B; Hérault O; Charbord P; Domenech J
Stem Cells; 2007 Jul; 25(7):1737-45. PubMed ID: 17395768
[TBL] [Abstract][Full Text] [Related]
11. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling.
Longobardi L; O'Rear L; Aakula S; Johnstone B; Shimer K; Chytil A; Horton WA; Moses HL; Spagnoli A
J Bone Miner Res; 2006 Apr; 21(4):626-36. PubMed ID: 16598383
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma.
Ryu CH; Park KY; Kim SM; Jeong CH; Woo JS; Hou Y; Jeun SS
Biochem Biophys Res Commun; 2012 May; 421(3):585-90. PubMed ID: 22525671
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
[TBL] [Abstract][Full Text] [Related]
14. Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity.
Pradier A; Passweg J; Villard J; Kindler V
Cell Transplant; 2011; 20(5):681-91. PubMed ID: 21054933
[TBL] [Abstract][Full Text] [Related]
15. Trichostatin A modulates intracellular reactive oxygen species through SOD2 and FOXO1 in human bone marrow-mesenchymal stem cells.
Jeong SG; Cho GW
Cell Biochem Funct; 2015 Jan; 33(1):37-43. PubMed ID: 25515622
[TBL] [Abstract][Full Text] [Related]
16. Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease.
Linares GR; Chiu CT; Scheuing L; Leng Y; Liao HM; Maric D; Chuang DM
Exp Neurol; 2016 Jul; 281():81-92. PubMed ID: 27085395
[TBL] [Abstract][Full Text] [Related]
17. Transduction of human EPO into human bone marrow mesenchymal stromal cells synergistically enhances cell-protective and migratory effects.
Kim MH; Cho GW; Huh YM; Kim SH
Mol Biol (Mosk); 2010; 44(4):656-63. PubMed ID: 20873225
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptors 2 and 4 mediate the capacity of mesenchymal stromal cells to support the proliferation and differentiation of CD34⁺ cells.
Wang X; Cheng Q; Li L; Wang J; Xia L; Xu X; Sun Z
Exp Cell Res; 2012 Feb; 318(3):196-206. PubMed ID: 22100911
[TBL] [Abstract][Full Text] [Related]
19. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
20. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells.
Andrades JA; Han B; Becerra J; Sorgente N; Hall FL; Nimni ME
Exp Cell Res; 1999 Aug; 250(2):485-98. PubMed ID: 10413602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
